AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

LB Pharmaceuticals Inc Common Stock

$39.70 +$19.26 (+94.23%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$40.15
Day Range
$39.12$41.24
Year Range
$14.32$50.16
Market Cap
1.28B
AVG Volume
365.19K
Trailing/Forward PE
-13.37/-
PEG ratio
-0.33
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Net Income (USD) · TTM
-100M-75M-50M-25M025 Q426 Q126 Q2
LBRX Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-85.69M
26 Q1-39.17M
25 Q4-25.2M
Operating Income (USD) · TTM
-100M-75M-50M-25M025 Q426 Q126 Q2
LBRX Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-95.14M
26 Q1-46.86M
25 Q4-30.4M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: LBRX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

LB Pharmaceuticals Inc Common Stock
LBRX
Stockpicker

Video analysis: LBRX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LBRX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.